The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin a nephropathy: A randomized controlled trial

Journal of Renal Nutrition

Volumn 24, Issue 3, 2014, Pages 200-207

  Kittiskulnam, Piyawan ^a   Kanjanabuch, Talerngsak ^a   Tangmanjitjaroen, Kannika ^b   Chancharoenthana, Wiwat ^a   Praditpornsilpa, Kearkiat ^a   Eiam Ong, Somchai ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LEPTIN; PROTEIN INTAKE;

ADMINISTRATION AND DOSAGE; ADULT; BLOOD; BLOOD PRESSURE; BODY COMPOSITION; CALORIC RESTRICTION; COMPLICATION; CONTROLLED STUDY; FEMALE; GLOMERULONEPHRITIS, IGA; HUMAN; MALE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PROTEIN INTAKE; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; THAILAND; URINE; WEIGHT REDUCTION;

ADIPONECTIN; ADULT; BLOOD PRESSURE; BODY COMPOSITION; CALORIC RESTRICTION; DIETARY PROTEINS; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; LEPTIN; MALE; MIDDLE AGED; OVERWEIGHT; PROSPECTIVE STUDIES; PROTEINURIA; THAILAND; WEIGHT LOSS;

EID: 84898900491     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2014.01.016     Document Type: Article

References (27)

1. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004, 24:179-196.
2. Coppo R., D'Amico G. Factors predicting progression of IgA nephropathy. J Nephrol 2005, 18:503-512.
3. Zoja C., Benigni A., Remuzzi G. Cellular responses to protein overload: key event in renal disease progression. Curr Opin Nephrol Hypertens 2004, 13:31-37.
4. Epstein F.H. Pathophysiology of progressive nephropathies. N Eng J Med 1998, 339:1448-1456.
5. Szeto C.C., Lai F.M.M., To K.F., et al. The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria. Am J Med 2001, 110:434-437.
6. Kidney Disease Improving Global Outcomes Clinical Practice Guideline for glomerulonephritis. Kidney Int Suppl 2012, 2:139-274.
7. Wyatt R.J., Julian B.A. IgA nephropathy. N Eng J Med 2013, 368:2402-2414.
8. Rutkowski P., Klassen A., Psych D., et al. Renal disease in obesity: the need for greater attention. J Ren Nutr 2006, 16:216-223.
9. Eknoyan G. Obesity and chronic kidney disease. Nefrologia 2011, 31:397-403.
10. Maddox D.A., Alavi F.K., Santella R.N., Zawada E.T. Prevention of obesity-linked renal disease: age dependent effect of dietary food restriction. Kidney Int 2002, 62:208-219.
11. Chagnac A., Weinstein T., Herman M., et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003, 14:1480-1486.
12. Axelssson J., Heimburger O., Lindholm B., Stenvinkel P. Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr 2005, 15:131-136.
13. Morales E., Praga M. The effects of weight loss in obesity and chronic kidney disease. Curr Hypertens Rep 2012, 14:170-176.
14. Morales E., Valero A., Leon M., Hernandez E., Praga M. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003, 41:319-327.
15. World Health Organization Western Pacific Region. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. 2000. Accessed September 30,2013. http://www.wpro.who.int/nutrition/documents/docs/Redefiningobesity.pdf.
16. Abou Mrad R.M., Abu-Alfa A.K., Ziyadeh F.N. Effects of weight reduction regimens and bariatric surgery on chronic kidney disease in obese patients. Am J Physiol Ren Physiol 2013, 305:F613-F617.
17. Ibrahim H.N., Weber M.L. Weight loss: a neglected intervention in the management of chronic kidney disease. Curr Opin Nephrol Hypertens 2010, 19:534-538.
18. Wang Y.L., Shu K.H., Yang M.F., et al. The impact of body weight management in chronic kidney disease patients with obesity. J Ren Nutr 2013, 23:372-379.
19. Golubovic M.V., Dimic D., Antic S., et al. Relationship of adipokine to insulin sensitivity and glycemic regulation in obese woman-the effect of body weight reduction by caloric restriction. Vojnosanit Pregl 2013, 70:284-291.
20. Patil M.R., Mishra A., Jain N., Gutch M., Tewari R. Weight loss for reduction of proteinuria in diabetic nephropathy: comparison with angiotensin-converting enzyme inhibitor therapy. Indian J Nephrol 2013, 23:108-113.
21. Navaneethan S.D., Yehnert H., Moustarah F., et al. Weight loss intervention in chronic kidney disease: a systematic review and meta analysis. Clin J Am Soc Nephrol 2009, 4:1565-1574.
22. Afshinnia F., Wilt T.J., Duval S., Esmaeili A., Ibrahim H.N. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant 2010, 25:1173-1183.
23. Chudek J., Adamczak M., Nieszporek T., Wiecek A. The adipose tissue as an endocrine organ-a nephrologist's perspective. Obesity and the Kidney Contributions to Nephrology 2006, 70-90. Karger, Basel, Switzerland. G. Wolf (Ed.).
24. Ross W.R., McGill J.B. Epidemiology of obesity and chronic kidney disease. Adv Chronic Kidney Dis 2006, 13:325-335.
25. Zoccali C., Mallamaci F. Adiponectin and leptin in chronic kidney disease: causal factors or mere risk markers?. J Ren Nutr 2011, 21:87-91.
26. Nasrallah M.P., Ziyadeh F.N. Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney. Semin Nephrol 2013, 33:54-65.
27. Ahima R.S. Linking adiponectin to proteinuria. J Clin Invest 2008, 118:1619-1622.